Search criteria | ||||
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study | ||||
Jonathan Gladstone 1, Sameer Chhibber 2, Jagdeep Minhas 3, Calum S Neish 3, G Sarah Power 3, Zhiyi Lan 3, Driss Rochdi 4, Jessica Lanthier-Martel 4, Natacha Bastien 4 | ||||
1Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada. 2Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 3Real-world Solutions, IQVIA, Kirkland, Québec, Canada. 4Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada. | ||||
Headache The Journal of Head and Face Pain PMID: 34807454 DOI: 10.1111/head.14218 |
||||
, Article | ||||
, Canada | ||||
Abstract: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14218 | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2022 | English | , Clinical setting: Primary care, direct to patient research | |
Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands | ||||
Hanne van Ballegooijen 1, Lucas Goossens 2, Ralph H Bruin 3, Renée Michels 3, Marieke Krol 3 | ||||
1IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com. 2Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. 3IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. | ||||
1 IQVIA, Herikerbergweg 314, 1101 CT Amsterdam, The Netherlands. 2 Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands BMC Health Services Research (2021) 21:227 PMID: 33712010 PMCID: PMC7953179 DOI: 10.1186/s12913-021-06240-7 |
||||
, Article | ||||
, Netherlands | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33712010/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health status & patient reported outcomes, Immunology and Vaccination | 2021 | English | , Observational study, Patient questionnaire, Population Based Study, Public Health, Quality of life, Survey research | |
Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety. | ||||
Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-Gabarró 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13 | ||||
1Real World Solutions, IQVIA, London, UK. 2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK. 3Data & Computational Sciences, GSK, London, UK. 4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA. 5Gillian Hall Epidemiology Ltd, London, UK. 6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA. 7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. 8Bayer AG, Berlin, Germany. 9PRA Health Sciences, Raleigh, North Carolina, USA. 10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. 11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. 12The Procter & Gamble Company, Cincinnati, Ohio, USA. 13UCB Pharma, Anderlecht, Belgium. | ||||
Pharmacoepidemiol Drug Saf . 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13. |
||||
, Article | ||||
, Belgium, Germany, UK, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33146896/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods | 2021 | English | , Patient questionnaire, Review | |
Quantifying the burden of the treatment-resistant depression in Ontario: Shredding light on an inportant mental health issue | ||||
Brad Millson, G Sarah Power, Dr. Roger S. McIntyre | ||||
Brad Millson, G Sarah Power, IQVIA RWE team | ||||
CADTH 2020 |
||||
, Article | ||||
, Canada | ||||
Abstract: hhttps://www.sciencedirect.com/science/article/pii/S0165032720324903 | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Mental health | 2020 | English | , Retrospective cohort analysis | |
RWE is the Future of Clinical Research: Time to Get Onboard | ||||
Nancy A. Dreyer, | ||||
Chief Scientific Officer and Senior VP, IQVIA Real World Solutions | ||||
PharmaVOICE - March 2020 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.pharmavoice.com/article/2020-03-rwe-research/#:~:text=We've%20been%20talking%20about,tools%20are%20coming%20into%20use. | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health status & patient reported outcomes | 2020 | English | , Economic evaluation, Literature Review, Market impact | |
Considerations when evaluating real-world data quality in the context of fitness for purpose | ||||
Matthew W Reynolds 1, Alison Bourke 2, Nancy A Dreyer 3 | ||||
1Real World Solutions, IQVIA, Maryland, USA. 2Real World Solutions, IQVIA United Kingdom, UK. 3Real World Solutions, IQVIA, Massachusetts, USA. | ||||
Pharmacoepidemiol Drug Saf . 2020 Oct;29(10):1316-1318. doi: 10.1002/pds.5010. Epub 2020 May 6. |
||||
, Article | ||||
, UK, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32374042/ | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2020 | English | , Real World Data, Real World Evidence | |
Bridging the Gap Between RCTs and RWE Through Endpoint Selection | ||||
Robert J LoCasale 1, Chris L Pashos 2, Ben Gutierrez 3, Nancy A Dreyer 4, Toby Collins 5, Alan Calleja 5, Michael J Seewald 6, Jonathan M Plumb 7, Johan Liwing 8, Maurille Feudjo Tepie 9, Sajan Khosla 10 | ||||
1Real World Evidence, Sanofi, Bridgewater, NJ, USA. 2AbbVie, Chicago, IL, USA. 3GSK, Philadelphia, PA, USA. 4IQVIA, Real-World Solutions, Cambridge, MA, USA. 5IQVIA, Real-World Solutions, London, UK. 6Novartis Pharma AG/Pharma Medical Affairs, Basel, Switzerland. 7Ferring Pharmaceuticals SA, St Prex, Switzerland. 8CellProtect Nordic Pharmaceuticals, Stockholm, Sweden. 9Center for Observational Research, Amgen, Cambridge, UK. 10Real-World Evidence Center of Excellence, AstraZeneca, Cambridge, UK. sajan.khosla@astrazeneca.com. | ||||
Published online 2020 Jul 6. doi: 10.1007/s43441-020-00193-5 |
||||
, Article | ||||
, Sweden, Switzerland, UK, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785541/ | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2020 | English | , Real World Data, Real World Evidence | |
The Certainty Framework for Assessing Realâ€World Data in Studies of Medical Product Safety and Effectiveness | ||||
Noelle M. Cocoros Peter Arlett Nancy A. Dreyer Chieko Ishiguro Solomon Iyasu Miriam Sturkenboom Wei Zhou Sengwee Toh | ||||
1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 2Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands. 3London School of Hygiene and Tropic Medicine, London, UK. 4Center for Advanced Evidence Generation, IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Division of Epidemiology, Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. 6Center for Observational and Real-world Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA. 7Julius Center, Global Health, University Medical Center Utrecht, Utrecht, The Netherlands. | ||||
https://doi.org/10.1002/cpt.2045 |
||||
, Article | ||||
, Japan, Netherlands, USA | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2045 | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2020 | English | , direct to patient research, Real World Data, Real World Evidence | |
Dose increase beyond labelled dose of biologics is associated with incremental pharmacy costs: results from a real-world study in the UK | ||||
Anthony Bewley 1, Cristiana Miglio 2, Haijun Tian 3, Isabelle Gilloteau 4, Joannah Whitehead 5, Ruben Hermans 2 | ||||
1a Whipps Cross University Hospital , London , UK. 2b IQVIA , London , UK. 3c Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA. 4d Novartis Pharma AG , Novartis Campus , Basel , Switzerland. 5e Novartis UK Pharmaceuticals Ltd , Frimley, Camberley , UK. | ||||
J Dermatolog Treat . 2019 Jun;30(4):376-382. doi: 10.1080/09546634.2018.1524820. Epub 2018 Nov 19. |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/30256686/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Guidelines, Health status & patient reported outcomes, Infectious disease, Infectious disease | 2019 | English | , Burden of illness, Clinical setting: Primary care, direct-to-patient research, Observational study | |
PRS72 DRUG TREATMENT PATTERNS FOR PULMONARY ARTERIAL HYPERTENSION PATIENTS IN ENGLAND: A RETROSPECTIVE ANALYSIS USING HOSPITAL TREATMENT INSIGHTS DATABASE | ||||
A. Beaudet A. Yesufu-Udechuku E.W. Davies L.H. Taylor S. Sikander-Rehman R. Ogley F. Exposto | ||||
Actelion Pharmaceuticals Ltd., Allschwill, BL, Switzerland Actelion Pharmaceuticals UK Ltd, London, UK Actelion Pharmaceuticals Ltd., Allschwill, BL, Switzerland IQVIA, London, UK | ||||
Open ArchiveDOI:https://doi.org/10.1016/j.jval.2019.09.2561 |
||||
, Poster | ||||
, England | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)34939-3/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Drug safety, Drug Utlization Study, Health status & patient reported outcomes | 2019 | English | , Public Health, Real World Data, Retrospective cohort analysis, Retrospective Field Study | |
Dose increase beyond labelled dose of biologics is associated with incremental pharmacy costs: results from a real-world study in the UK | ||||
Anthony Bewley 1, Cristiana Miglio 2, Haijun Tian 3, Isabelle Gilloteau 4, Joannah Whitehead 5, Ruben Hermans 2 | ||||
1a Whipps Cross University Hospital , London , UK. 2b IQVIA , London , UK. 3c Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA. 4d Novartis Pharma AG , Novartis Campus , Basel , Switzerland. 5e Novartis UK Pharmaceuticals Ltd , Frimley, Camberley , UK. | ||||
PMID: 30256686 DOI: 10.1080/09546634.2018.1524820 |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/30256686/ | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study, Guidelines, Health status & patient reported outcomes | 2019 | English | , direct-to-patient research, Methodology, Survey research | |
Bringing patient-generated data into pharmacoepidemiology: The who, what, why, where, when and how. | ||||
Dixon WG, Bartels DB, Curtis J, Bourke A, Martin D, Lin KJ. | ||||
Pharmacoepidemiol Drug Saf 2018; 27 (2):22-23. |
||||
, Workshop | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2018 | English | ||
Depression is Associated with Chronic Disorders in Children and Adolescents | ||||
Kostev K, Dombrowski S, Konrad M | ||||
IQVIA, Frankfurt am Main, Germany, FOM University of Applied Sciences, Frankfurt am Main, Germany | ||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Mental health, Pediatrics | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Dutch health state utilities for infertility and subfertility. | ||||
Krol M, Nap A, Michels RM, Veraart CPWM, Goossens LMA | ||||
IQVIA, Netherlands | ||||
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain |
||||
, Abstract | ||||
, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health status & patient reported outcomes | 2018 | English | , Quality of life, Utility analysis | |
Developing a Multiphase Claims-Based Algorithm for Non-Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Developing a Multiphase Claims-Based Algorithm for Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the ‘TOL-AR-18 Questionnaire | ||||
Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartà R | ||||
Corominas H.: Rheumatology and Autoimmune diseases Division, Hospital Universitari de Sant Pau & Hospital Dos de Maig, Barcelona, Spain Sarmiento M: Real-World Evidence Solutions, IMS Health, Spain | ||||
ReumatologÃa ClÃnica 2018; Sep 5. [Epub ahead of print] |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.reumatologiaclinica.org/en/assessing-treatment-tolerability-for-rheumatoid/avance-resumen/S1699258X18301232/ | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Rheumatology | 2018 | English | , Clinical setting: hospital, Observational study | |
Healthcare-seeking behaviour of primary caregivers for acute otitis media in children aged 6 months to <30 months in Panama: results of a cross-sectional survey. | ||||
Villarreal I, Turner R, Jo H, Park J, Gemmen E, et al. | ||||
BMC Pediatrics |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Pediatrics | 2017 | English | ||
Real-world treatment patterns and outcomes for mNSCLC patients receiving second- and third-line therapy in Germany | ||||
Yu N1, Rivera I2, Hipp J3, Zou M4, Pillai N4, Hammerschmidt S5 | ||||
1 Roche Products Ltd, Welwyn, UK 2 F. Hoffmann-La Roche, Basel, Switzerland 3 Roche Pharma AG, Grenzach-Wyhlen, Germany 4 QuintilesIMS, Basel, Switzerland 5 Klinikum Chemnitz gGmbH, Chemnitz, Germany | ||||
, Poster | ||||
, Germany | ||||
Abstract: https://academic.oup.com/annonc/article/28/suppl_2/mdx091.052/3799717/132PReal-world-treatment-patterns-and-outcomes-for | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health status & patient reported outcomes, Oncology | 2017 | English | , clinical setting: Secondary care, Patient questionnaire, Quality of life | |
Spanish cultural adaptation of the short version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) | ||||
MartÃnez-Ginés ML, GarcÃa-DomÃnguez JM, Sarmiento M, Maurino J | ||||
MartÃnez-Ginés ML: Servicio de NeurologÃa, Hospital Universitario Gregorio Marañón, Madrid, España Sarmiento M: QuintilesIMS, Barcelona, España | ||||
NeurologÃa 2017; Apr 5 [Epub ahead of print] |
||||
, Letter | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/es-revista-neurologia-295-avance-resumen-adaptacion-cultural-al-espanol-del-S0213485317301056 | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Neurological disorders | 2017 | Spanish | , Patient questionnaire | |
STATISTICAL MODELS TO PREDICT INDICATION OF RESPIRATORY PATIENTS BETWEEN ASTHMA AND COPD | ||||
Ilgin Y, Staus A, Chauvin F, Leheyda N, Wolk A, Witte M, Subramani S | ||||
19th ISPOR congress 2016 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Methodology, Respiratory disease | 2016 | English | , Methodology, Retrospective database analysis | |
Quantification of patient preference analysis_Wearing the federal joint committee lens to assess evidence | ||||
Gaba D1, Eheberg D, Bonduelle D | ||||
1 Quintiles IMS, Gurgaon, India 2 QuintilesIMS, Munich, Germany | ||||
, Poster | ||||
, Germany, India | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Pricing and reimbursement | 2016 | English | , Pricing & Reimbursement | |
Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in England | ||||
Ahir HB1, McCann E2, Robertson S1, Patel S1, Yu E3, Tham R3 | ||||
1MSD Ltd, Hoddesdon, UK, 2Merck & Co., Kenilworth, NJ, USA, 3IMS Health, London, UK | ||||
Open ArchiveDOI:https://doi.org/10.1016/j.jval.2016.09.431 |
||||
, Poster | ||||
, UK | ||||
Abstract: https://www.valueinhealthjournal.com/action/showPdf?pii=S1098-3015%2816%2931798-3 | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Drug Utlization Study, Health status & patient reported outcomes | 2016 | English | , Clinical setting: Primary care, direct-to-patient research, Real World Evidence, Review | |
Psychometric validation of the Brief Pain Inventory- Short Form in patients with systemic lupus erythematosus in the United States | ||||
Sawah SA, Naegeli AN, Gemmen E, Tomaszewski EL, Lane NE | ||||
Lupus Journal. In Press. 2015 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2015 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Identifying symptoms and impacts experienced by men with non-metastatic castration resistant prostate cancer | ||||
Tomaszewski EL, Krupnick R, Moïse P, Downing J, Holmstrom S | ||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2014 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Recruiting and interviewing non-metastatic castration resistant cancer patients for qualitative study participation via an internet-based digital patient community | ||||
Tomaszewski EL, Krupnick R, Moïse P, Downing J, Holmstrom S | ||||
ISPOR 19th Annual International Meeting, Montreal, QC, Canada. June 2014 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2014 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
AN Psychometric Validation of Patient-Reported Outcome Measures of Pain in US Patients with Systemic Lupus Erythematosus | ||||
Sawah, SA, Tomaszewski, EL, Naegeli | ||||
ISPOR 19th Annual International Meeting, Montreal, QC, Canada. June 2014 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2014 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Psychometric Properties of the Brief Fatigue Inventory in Systemic Lupus Erythematosus | ||||
Sawah, SA, Tomaszewski, EL, Gemmen, E, Naegeli | ||||
ISPOR 19th Annual International Meeting, Montreal, QC, Canada. June 2014 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2014 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study | ||||
Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, SuZ, Mun Y, Sloan JA, Kaufman PA | ||||
Breast 2014; Sep 2. pii: S0960-9776(14)00140-4. doi: 10.1016/j.breast.2014.08.004 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2014 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Comparison of treatment satisfaction in patients with asthma taking leukotriene modifiers versus those taking inhaled corticosteroids | ||||
Tomaszewski EL, Mendelsohn AB, Shah AJ | ||||
International Society of Pharmacoeconomics and Outcomes Research, November 2013, Dublin, Ireland |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2013 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
The correlation between patient report outcomes and clinician reported outcomes | ||||
Gemmen E, Zarzar K, Kamble S, Dawsey R | ||||
ISPOR, 18th Annual Meeting, New Orleans, LA, May 2013 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2013 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura during the A/H1N1 (2009) influenza pandemic | ||||
Reynales H, Astudillo P, Vallière S, Hatz C, Schlagenhauf P, Rath B, Velentgas P, Fariña A, Sales-Carmona V, Groth N | ||||
Vaccine. 2012. Oct 5;30(45):6436-43. doi: 10.1016/j.vaccine.2012.08.005. Epub 2012 Aug 15 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Capturing breast cancer patients experience beyond disease progression: Implementation of a patient-reported outcome (PRO) substudy in the VIRGO metastatic breast cancer observational cohort study | ||||
Kaufman PA, Dreyer NA, Mayer M, Sloan JA, Chung CY, Sing A, Yim YM, Yu E, Mathias SD, Cleeland CS | ||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2010 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Validation of an Abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among Patients on Antihypertensive Medications | ||||
Bharmal M, Payne K, Atkinson M, Desrosiers M, Morisky D, Gemmen E | ||||
Health & Quality of Life Outcomes 2009 Apr 27;7:36 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2009 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Validation of an Abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among Patients on Antihypertensive Medications | ||||
Bharmal M, Payne K, Atkinson M, Desrosiers M, Morisky D, Gemmen E | ||||
Health & Quality of Life Outcomes 2009 Apr 27;7:36 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2009 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Prospective assessment of long-term health outcomes following mesh hernia repair: the international hernia mesh registry | ||||
Bringman S, N Dreyer, BT Heniford, B Ramshaw, LT Divilio, DL Simpkins | ||||
European Hernia Society. May, 2008 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2008 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
American Orthopaedic Association's "Own the Bone" initiative to prevent secondary fractures | ||||
Tosi LL, Gliklich RE, Kannan K, Koval KJ | ||||
Journal of Bone and Joint Surgery (American) 2008; 90:163-173. |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2008 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Generic and specific quality-of-life measures in Taiwanese adults with sleep-disordered breathing | ||||
Wang PC, Li HY, Shih TS, Gliklich RE, Chen NH, Liao YF | ||||
Otolaryngol Head Neck Surg 2006; 135(3):421-426 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes | 2006 | English | , RWLPR (Real-World Late Phase Research-quintiles | |